|
|
||||||||
Eur J Cardiothorac Surg 2005;28:194-198
© 2005 Elsevier Science NL
Original articles |
a Cardiothoracic Department, The 1st Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, China
b Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Received 7 October 2004; received in revised form 11 December 2004; accepted 17 December 2004.
* Corresponding author. Address: Service de Chirurgie CardioVasculaireBH10, Centre Hospitalier Universitaire VaudoisCHUV, Rue du Bugnon, 46, CH-1011 Lausanne, VD, Switzerland. Tel.: +41 21 314 22 80; fax: +41 21 314 22 78. (Email: piergiorgio.tozzi{at}hospvd.ch).
Abstract
Objective: An animal model has been designed to assess the feasibility of off-pump mitral valve replacement using valved stents. Methods: Glutaraldehyde-preserved homograft was sutured inside a prosthetic tube (Dacron). Then, two self-expandable nitinol Z-stents were sutured on the external surface of the prosthesis in such a way to create two self-expanding crowns for fixation. In adult pigs and under general anesthesia, the left atrium was exposed through a left thoracotomy and atrio-ventricular roadmapping was performed with intravascular ultrasound (IVUS) and fluoroscopy. The double-crowned valved stents were loaded into a delivery sheath. The sheath was then introduced into the left atrium and the valved stents was deployed in mitral position in such a way that the part in between the two stents was at the level of the mitral annulus. Intracardiac Unltrasound (ICUS) was used to assess the valve function. Hemodynamic parameters were gathered as well. Animal survived for no more than 3h after the valve deployment and gross anatomy examination of the left heart was carried out. Results: The mean height of the valved stents was 29.4±0.2mm, with an internal diameter of 20.4±1.0mm, and an external diameter of 25.5±0.8mm. The procedure was successfully carried out in eight animals. In vivo evaluation showed a native mitral annulus diameter of 24.9±0.6mm, and a mean mitral valve area of 421.4±17.5mm2. ICUS showed a mild mitral regurgitation in three out of eight animals. Mean pressure gradient across the valved stents was 2.6±3.1mmHg. Mean pressure gradient across the left ventricular outflow tract (LVOT) was 6.6±5.2mmHg. The mean survival time was 97.5±56.3min (survival time range was 40180min). One animal died due to the occlusion of the LVOT because of valved stents displacement. Postmortem evaluation confirmed correct positioning of the valved stent in the mitral position in seven out of eight animals. No atrial or ventricular lesions due to the valved stents were found. Conclusions: Off-pump implantation of a self-expandable valved stent in the mitral position is technically feasible. Further studies will assess if this procedure is also feasible in humans.
Key Words: Self-expandable valved stent Mitral valve replacement Off-pump cardiac surgery
This article has been cited by other articles:
![]() |
G. Lutter, R. Quaden, S. Osaki, J. Hu, J. Renner, N. M. Edwards, J. Cremer, and L. Lozonschi Off-pump transapical mitral valve replacement Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 124 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kempfert, J. Blumenstein, M. W.A. Chu, P. Pritzwald-Stegmann, T. Kobilke, V. Falk, F. W. Mohr, and T. Walther Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 965 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Masson and J. G. Webb Percutaneous Treatment of Mitral Regurgitation Circ Cardiovasc Interv, April 1, 2009; 2(2): 140 - 146. [Full Text] [PDF] |
||||
![]() |
L. Lozonschi, R. Quaden, N. M. Edwards, J. Cremer, and G. Lutter Transapical Mitral Valved Stent Implantation Ann. Thorac. Surg., September 1, 2008; 86(3): 745 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Antunes Off-pump aortic valve replacement with catheter-mounted valved stents.: Is the future already here? Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
C. Schreiber, J. Horer, M. Vogt, S. Fratz, M. Kunze, C. Galm, A. Eicken, and R. Lange A new treatment option for pulmonary valvar insufficiency: first experiences with implantation of a self-expanding stented valve without use of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Huber and L. K. von Segesser Direct Access Valve Replacement (DAVR) -- are we entering a new era in cardiac surgery? Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 380 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lutter and J. Cremer Editorial comment: Off-pump mitral valve replacement: an attack on conventional heart surgery? Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 198 - 199. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |